Nippon India Taiwan Equity fund- Regular Plan- Growth Option
💡 Why Pick This Fund? Quantitative Strengths & Watch-outs
- Outperformed category benchmark in 73% of historical 3-year rolling periods.
- Strong capital defense: downside capture of -77% limits losses during market corrections.
- Generated +37.7% annualized alpha (excess return) over its benchmark.
- Experienced a maximum drawdown of -45.5% during severe market crashes.
Key Statistics vs Category Median
Trailing Returns Comparison
| Period | Fund Return | Category Median | Difference |
|---|---|---|---|
| 1 Month | -26.73% | +6.32% | -33.05% |
| 3 Months | -19.27% | -0.20% | -19.07% |
| 6 Months | -23.73% | +5.98% | -29.71% |
| 1 Year | +62.43% | +3.90% | +58.53% |
| 3 Years CAGR | +45.47% | +13.23% | +32.24% |
| Since Inception | +23.13% | - | - |
📈 Monthly SIP vs Bank Fixed Deposit (FD) Replay
See how a regular monthly SIP in Nippon India Taiwan Equity fund compares against a standard 7.0% p.a. Bank Fixed Deposit.
Calendar Year Returns
| Year | Fund | Category Median | Gap |
|---|---|---|---|
| 2026 | +50.47% | +4.03% | +46.44% |
| 2025 | +50.74% | +1.43% | +49.31% |
| 2024 | +24.22% | +20.41% | +3.81% |
| 2023 | +44.53% | +30.70% | +13.83% |
| 2022 | -34.39% | +1.66% | -36.05% |
Daily Rolling Returns Summary
| Rolling Window | Minimum | Average | Median | Maximum | % Positive | % Beating Proxy |
|---|---|---|---|---|---|---|
| 1-Year Rolling | -34.66% | +47.48% | +32.72% | +274.26% | 84.7% | 64.5% |
| 3-Year Rolling | -3.03% | +35.27% | +37.43% | +67.87% | 99.5% | 72.7% |
Risk Profile & Deepest Drawdowns
Deepest Market Corrections (Depth >= 10%)
| Peak Date | Trough Date | Fall Depth | Months to Bottom | Recovery Period |
|---|---|---|---|---|
| 2022-01-04 | 2022-10-25 | -45.5% | 10 months | 15 months |
| 2026-06-03 | 2026-11-06 | -38.7% | 5 months | Not yet recovered |
| 2025-01-07 | 2025-04-09 | -37.8% | 3 months | 2 months |
Portfolio & Asset Allocation
Statutory Asset Allocation Mandate (SEBI / SID)
| Instrument Category | Permitted Allocation Range |
|---|---|
| Equity and Equity related Instruments listed on the recognized stock exchanges of Taiwan* - 80-100%; Debt and Money Market Instruments^ - 0-20%. | Per Scheme Mandate |
| *The fund will also invest in initial and follow on public offerings to be listed at recognized stock exchanges of Taiwan. | Per Scheme Mandate |
| ^Money market instruments include Tri-Party Repo/Re- verse Repo (including corpo- rate bond Repo), commercial papers (Listed), commercial bills, treasury bills, Government securities issued by Central & State Government having an unexpired maturity up to one year, call or notice money, certificate of deposit, usance bills, and Any other like instruments as specified by the Reserve Bank of India from time to time. | Per Scheme Mandate |
Investment Objective & Strategy
The primary investment objective of scheme is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on the recognized stock exchanges of Taiwan and the secondary objective is to generate consistent returns by investing in debt and money market securities of India. However, there can be no assurance or guarantee that the investment objective of the scheme will be achieved.
ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.
Fund Size Position
Currently managing Rs 806 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as comfortable relative to Sectoral / Thematic schemes.
Fund Management
Cost & Capital Gains Taxation
From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.
Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.
Closest Sectoral / Thematic Peers by Rank
| Scheme | Score | 3Y Return | Expense | Downside | Fund Size | Compare |
|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund | 7.9 | +22.67% | - | 45.7% | Rs 3,828 cr | Compare → |
| DSP Healthcare Fund | 8.0 | +20.31% | 2.04% | 53.2% | Rs 3,946 cr | Compare → |
| UTI Healthcare Fund | 7.0 | +22.74% | 2.20% | 57.0% | Rs 1,536 cr | Compare → |
| Aditya Birla Sun Life International Equity Fund | 5.8 | +20.53% | 2.55% | -28.3% | Rs 337 cr | Compare → |
| SBI HEALTHCARE OPPORTUNITIES FUND | 7.2 | +23.97% | 1.98% | 43.4% | Rs 6,504 cr | Compare → |
Frequently Asked Questions about Nippon India Taiwan Equity fund
What is the expense ratio of Nippon India Taiwan Equity fund?
Nippon India Taiwan Equity fund has a total expense ratio (TER) of 2.39% with a base expense ratio of 1.94%, compared to the Sectoral / Thematic category median of 2.52%.
Who manages Nippon India Taiwan Equity fund?
Nippon India Taiwan Equity fund is managed by Kinjal Desai.
What are the historical returns of Nippon India Taiwan Equity fund?
Nippon India Taiwan Equity fund delivered a 3-year CAGR of 45.47%. Its 1-year return stands at +62.43%.
How large is Nippon India Taiwan Equity fund?
Nippon India Taiwan Equity fund manages assets of Rs 806 cr, placing it in the 'comfortable' size band relative to Sectoral / Thematic peers.
How is Nippon India Taiwan Equity fund scored on MFIQ?
Nippon India Taiwan Equity fund holds an MFIQ Score of 7.2/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.
How risky is Nippon India Taiwan Equity fund?
Nippon India Taiwan Equity fund has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 38.07% with a maximum historical drawdown of -45.52%.